Peroxisome proliferator-activated receptor alpha (PPARα) has been involved in the regulation of somatotroph tumour cells and may be targeted by different drugs, some of them are in current clinical use. The aim of this study was to investigate the expression of PPARα in additional phenotypes of pituitary adenomas (PA), the relationship between PPARα and its potential molecular partner aryl hydrocarbon receptor interacting protein (AIP) in these tumours, and the effects of PPARα agonists on lactotroph cells. Seventy-five human PA - 57 non-functioning (NFPA) and 18 prolactinomas (PRL-PA) - were characterised for PPARα and AIP expression by real time RT-PCR and/or immunohistochemistry (IHC), and the effects of fenofibrate and WY 14 643 on MMQ cells were studied in vitro. PPARα was expressed in a majority of PA. PPARα immunostaining was observed in 93.7% PRL-PA vs. 60.6% NFPA (p=0.016), the opposite being found for AIP (83.3% in NFPA vs. 43.7% in PRL-PA, p=0.003). PPARα expression was unrelated to gonadotroph differentiation in NFPA, but positively correlated with tumour volume in PRL-PA. Both drugs significantly reduced MMQ cell growth at high concentrations (100-200 μM). At the same time, despite modest stimulating effects on PRL secretion were observed, these were overcome by the reduction in cell number. In conclusion, PPARα is commonly expressed by PRL-PA and NFPA, regardless of AIP, and may represent a new target of PPARα agonists.

Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ Cells / Polidoro, Michela Anna; Rotondi, Sandra; Morace, Roberta; Rostomyan, Liliya; Colapietro, Alessandro; Arcella, Antonietta; Ventura, Luca; Angelucci, Adriano; Giangaspero, Felice; Esposito, Vincenzo; Beckers, Albert; Jaffrain-Rea, Marie-Lise. - In: HORMONE AND METABOLIC RESEARCH. - ISSN 0018-5043. - 50:8(2018), pp. 640-647. [10.1055/a-0633-2706]

Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ Cells

Morace, Roberta;Arcella, Antonietta;VENTURA, LUCA;Giangaspero, Felice;Esposito, Vincenzo;
2018

Abstract

Peroxisome proliferator-activated receptor alpha (PPARα) has been involved in the regulation of somatotroph tumour cells and may be targeted by different drugs, some of them are in current clinical use. The aim of this study was to investigate the expression of PPARα in additional phenotypes of pituitary adenomas (PA), the relationship between PPARα and its potential molecular partner aryl hydrocarbon receptor interacting protein (AIP) in these tumours, and the effects of PPARα agonists on lactotroph cells. Seventy-five human PA - 57 non-functioning (NFPA) and 18 prolactinomas (PRL-PA) - were characterised for PPARα and AIP expression by real time RT-PCR and/or immunohistochemistry (IHC), and the effects of fenofibrate and WY 14 643 on MMQ cells were studied in vitro. PPARα was expressed in a majority of PA. PPARα immunostaining was observed in 93.7% PRL-PA vs. 60.6% NFPA (p=0.016), the opposite being found for AIP (83.3% in NFPA vs. 43.7% in PRL-PA, p=0.003). PPARα expression was unrelated to gonadotroph differentiation in NFPA, but positively correlated with tumour volume in PRL-PA. Both drugs significantly reduced MMQ cell growth at high concentrations (100-200 μM). At the same time, despite modest stimulating effects on PRL secretion were observed, these were overcome by the reduction in cell number. In conclusion, PPARα is commonly expressed by PRL-PA and NFPA, regardless of AIP, and may represent a new target of PPARα agonists.
2018
aryl hydrocarbon receptor interacting protein (AIP); fenofibrate; non-functioning pituitary adenomas; nuclear receptors; prolactinomas; WY 14 643; Adolescent; Adult; Aged; Cell Proliferation; Female; Fenofibrate; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Male; Middle Aged; PPAR alpha; Pituitary Neoplasms; Prolactinoma; Pyrimidines; Somatotrophs; Young Adult; Endocrinology, Diabetes and Metabolism; Biochemistry; Endocrinology; Clinical Biochemistry; Biochemistry (medical)
01 Pubblicazione su rivista::01a Articolo in rivista
Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ Cells / Polidoro, Michela Anna; Rotondi, Sandra; Morace, Roberta; Rostomyan, Liliya; Colapietro, Alessandro; Arcella, Antonietta; Ventura, Luca; Angelucci, Adriano; Giangaspero, Felice; Esposito, Vincenzo; Beckers, Albert; Jaffrain-Rea, Marie-Lise. - In: HORMONE AND METABOLIC RESEARCH. - ISSN 0018-5043. - 50:8(2018), pp. 640-647. [10.1055/a-0633-2706]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1236393
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact